Lanean...
The promises and challenges of erythropoietin for treatment of Alzheimer’s disease
Alzheimer’s disease (AD) is the most prevalent neurodegenerative disorder in the world, and intracellular neurofibrillary tangles and extracellular amyloid-beta protein deposits represent the major pathological hallmarks of the disease. Currently available treatments provide some symptomatic relief...
Gorde:
| Argitaratua izan da: | Neuromolecular Med |
|---|---|
| Egile Nagusiak: | , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2019
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6407698/ https://ncbi.nlm.nih.gov/pubmed/30656553 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12017-019-08524-y |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|